Last reviewed · How we verify
KD7040 Topical Gel
KD7040 Topical Gel is a topical gel formulation of a small molecule inhibitor.
KD7040 Topical Gel is a topical gel formulation of a small molecule inhibitor. Used for Actinic keratosis.
At a glance
| Generic name | KD7040 Topical Gel |
|---|---|
| Sponsor | Kalypsys, Inc. |
| Drug class | small molecule inhibitor |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | Phase 2 |
Mechanism of action
KD7040 Topical Gel is a topical formulation of a small molecule inhibitor that targets a specific pathway. This allows for localized delivery and potentially reduced systemic side effects.
Approved indications
- Actinic keratosis
Common side effects
- Skin irritation
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- KD7040 Topical Gel CI brief — competitive landscape report
- KD7040 Topical Gel updates RSS · CI watch RSS
- Kalypsys, Inc. portfolio CI